Literature DB >> 23047995

Challenges in management of complex panic disorder in a palliative care setting.

Itoro Udo1, Amanda Gash.   

Abstract

This is a complex case of post-traumatic stress disorder (PTSD) with comorbid panic disorder occurring in a woman in her mid-60s, with a family history of neurotic illness. PTSD arose in the context of treatment for terminal lung cancer. This patient who had been close to her father watched him die of cancer, when he was about her age. Her diagnosis and treatment prompted traumatic recollections of her father's illness and death that resulted in her voluntary withdrawal from cancer treatment. The goals of treatment were to promptly reduce anxiety, minimise use of sedating pharmacotherapy, promote lucidity and prolong anxiety-free state thereby allowing time for important family interactions. Prompt, sustained relief of severe anxiety was necessary to achieve comfort at the end of life. Skilled additions of psychological therapies (eye movement desensitisation reprocessing, clinical hypnosis and breathing exercises) with combined pharmacotherapy (mirtazepine and quetiapine) led to control of anxiety and reduction of post-traumatic stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23047995      PMCID: PMC4544155          DOI: 10.1136/bcr-2012-006800

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  [Montgomery GH, DuHamel KN, Redd WH: A meta-analysis of hypnotically induced analgesia: How effective is hypnosis? Int J Clin Exp Hypn 2000; 48: 138-153].

Authors:  I Kirsch; H Walach
Journal:  Forsch Komplementarmed Klass Naturheilkd       Date:  2000-10

2.  The art of suggestion: the use of hypnosis in dentistry.

Authors:  A Holden
Journal:  Br Dent J       Date:  2012-06-08       Impact factor: 1.626

Review 3.  Pediatric hypnosis: pre-, peri-, and post-anesthesia.

Authors:  Leora Kuttner
Journal:  Paediatr Anaesth       Date:  2012-06       Impact factor: 2.556

Review 4.  Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder.

Authors:  Robert J Ursano; Carl Bell; Spencer Eth; Matthew Friedman; Ann Norwood; Betty Pfefferbaum; J D Robert S Pynoos; Douglas F Zatzick; David M Benedek; John S McIntyre; Sara C Charles; Kenneth Altshuler; Ian Cook; C Deborah Cross; Lisa Mellman; Louis Alan Moench; Grayson Norquist; Stuart W Twemlow; Sherwyn Woods; Joel Yager
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

Review 5.  Review of the efficacy of clinical hypnosis with headaches and migraines.

Authors:  D Corydon Hammond
Journal:  Int J Clin Exp Hypn       Date:  2007-04

6.  Efficacy of EMDR in children: a meta-analysis.

Authors:  Roos Rodenburg; Anja Benjamin; Carlijn de Roos; Ann Marie Meijer; Geert Jan Stams
Journal:  Clin Psychol Rev       Date:  2009-06-24

7.  Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial.

Authors:  E V Lang; E G Benotsch; L J Fick; S Lutgendorf; M L Berbaum; K S Berbaum; H Logan; D Spiegel
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

Review 8.  Psychological treatments for chronic post-traumatic stress disorder. Systematic review and meta-analysis.

Authors:  Jonathan I Bisson; Anke Ehlers; Rosa Matthews; Stephen Pilling; David Richards; Stuart Turner
Journal:  Br J Psychiatry       Date:  2007-02       Impact factor: 9.319

9.  Brief eclectic psychotherapy v. eye movement desensitisation and reprocessing therapy for post-traumatic stress disorder: randomised controlled trial.

Authors:  Mirjam J Nijdam; Berthold P R Gersons; Johannes B Reitsma; Ad de Jongh; Miranda Olff
Journal:  Br J Psychiatry       Date:  2012-02-09       Impact factor: 9.319

10.  The Effects of Clinical Hypnosis versus Neurolinguistic Programming (NLP) before External Cephalic Version (ECV): A Prospective Off-Centre Randomised, Double-Blind, Controlled Trial.

Authors:  Joscha Reinhard; Swati Peiffer; Nicole Sänger; Eva Herrmann; Juping Yuan; Frank Louwen
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-21       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.